Zinc finger TRAF-type-containing protein 1 (ZFTRAF1)

Zinc finger TRAF-type-containing protein 1 (ZFTRAF1) is a protein encoded by the ZFTRAF1 gene in humans and is characterized by the presence of a TRAF-type zinc finger domain[1][3][8]. The protein is implicated in **zinc ion binding** and is localized to the nuclear envelope and perinuclear region of the cytoplasm[1][6][9][11]. Biallelic variants in ZFTRAF1 cause a severe neurodevelopmental disorder associated with microcephaly, hypotonia, and global developmental delay[2]. Functional studies suggest a possible role in **mRNA processing** and **autophagy-related pathways**, although no defined molecular function or pathway is fully elucidated[2]. There are currently no known drug interactions, mechanisms of drug action, or biomarker or safety data related to ZFTRAF1[1][2]. Key facts: - ZFTRAF1 is **not currently recognized as a therapeutic target** (receptor, enzyme, transporter, etc.), but is rather a protein of as-yet poorly understood function with causative variants linked to specific genetic disorders[1][2]. - It belongs to the general class of **zinc finger proteins**, specifically those with a TRAF-type zinc finger domain involved in protein-protein or protein-nucleic acid interactions[3][5]. - Present disease associations are confined to rare inherited neurodevelopmental disorders; no established links to common pathological processes such as cancer, inflammation, or infection are currently reported[2].

Other names

CYHR1KIAA0496CHRPMGC13010Cysteine and histidine-rich protein 1cysteine/histidine-rich 1zinc finger TRAF-type containing 1